Public annual accounts

TEREBENTHINE financials

Name: TEREBENTHINE financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for TEREBENTHINE, with comparable measures and links to available source documents.

Company overview

Registry number

0755345928

Fiscal coverage

2023–2024

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for TEREBENTHINE

2024 versus 2023

Operating line: €2,172
EBITDA: €1,813
Total assets: €40,712
Equity: €10,802

EBITDA margin +83.5% · Equity ratio +26.5%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202431 Dec 2024	€2,172	€1,813	€40,712	€10,802	-
202331 Dec 2023	€9,545	€9,198	€53,244	€9,537	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2023 to 2024 · Method family

Open report